
    
      The purpose of this study is to explore the differences in pharmacokinetics and safety
      characteristics between Test Drugs(DWJ1439, DWJ1464) and that of Reference Drugs(DWC202003,
      DWC202004) in healthy adults with fasting state: Randomized, open-label, oral, single-dose,
      four-treatment, three-period, non-replicated crossover study
    
  